|
|
|
Volumn 343, Issue , 2011, Pages
|
|
NICE rules out NHS prescription of fingolimod for multiple sclerosis.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DRUG DERIVATIVE;
FINGOLIMOD;
IMMUNOSUPPRESSIVE AGENT;
PRESCRIPTION DRUG;
PROPANEDIOL DERIVATIVE;
SPHINGOSINE;
COST BENEFIT ANALYSIS;
ECONOMICS;
HEALTH CARE COST;
HUMAN;
LEGAL ASPECT;
MULTIPLE SCLEROSIS;
NOTE;
PUBLIC HEALTH;
TREATMENT OUTCOME;
COST-BENEFIT ANALYSIS;
HEALTH CARE COSTS;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MULTIPLE SCLEROSIS, RELAPSING-REMITTING;
NATIONAL HEALTH PROGRAMS;
PRESCRIPTION DRUGS;
PROPYLENE GLYCOLS;
SPHINGOSINE;
TREATMENT OUTCOME;
|
|
EID: 83655189266
PISSN: None
EISSN: 17561833
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (3)
|
|
References (0)
|
